Odonate Therapeutics, Inc.
ODTDelisted Jan 25, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001717452
Odonate Therapeutics, Inc. was delisted on Jan 25, 2022; its insiders filed their last Form 4 on Dec 10, 2021; 50 institutions reported holding it in 13F filings for Q4 2021, worth $32.7M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 50
- Q4 2021, −8 vs. previous quarter
- 13F value
- $32.7M
- Reported value at the end of Q4 2021
- Superinvestors holding
- 0
- At the end of Q4 2021
Superinvestors holding ODT, Q4 2021
No superinvestor reported holding ODT at the end of Q4 2021.
Latest insider trades
Open-market purchases and sales by Odonate Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2021 (view filing) | Dec 1 | 9 daysLate | EcoR1 Capital, LLC10% Owner | PPurchase | +185.9K | $1.66 | +$308.7K | +3.4%5.70M after | |
| Dec 10, 2021 (view filing) | Dec 1-10 | 9 daysLate | EcoR1 Capital, LLC10% Owner | SSale | −5.89M | $1.65 | −$9.74M | −100.0%0 after | 4 lots |
| Nov 24, 2021 (view filing)6:00 PM ET | Nov 22-24 | 2 days | Lewis Joseph and 2 others10% Owner | SSale | −400.0K | $1.56 | −$623.3K | −8.7%4.21M after | 2 lots |
| Nov 19, 2021 (view filing)7:21 PM ET | Nov 17-19 | 2 days | Boxer Capital, LLC and 2 othersDirector, 10% Owner | SSale | −1.00M | $2.06 | −$2.06M | −17.8%4.61M after | 3 lots |
| Nov 19, 2021 (view filing)4:38 PM ET | Nov 17-19 | 2 days | Tang Kevin C and 3 othersChief Executive Officer | SSale | −2.75M | $2.09 | −$5.73M | −17.7%12.8M after | 8 lots |
| Nov 19, 2021 (view filing) | Nov 17-19 | 2 days | Davis Aaron I.Director, 10% Owner | SSale | −200.0K | $2.18 | −$436.7K | −31.0%445.8K after | 2 lots |
| Nov 19, 2021 (view filing) | Nov 17-19 | 2 days | Davis Aaron I.Director, 10% Owner | SSale | −1.00M | $2.07 | −$2.07M | −17.8%4.61M after | 3 lots |
Top 10 13F holders, Q4 2021
The largest institutional positions in Odonate Therapeutics, Inc. at the end of Q4 2021; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 12,767,435 | $17.2M | 3.47% | −2,747,131−17.7% | Reduced |
| Boxer Capital, LLC | 4,207,086 | $5.68M | 0.23% | −1,400,000−25.0% | Reduced |
| Ikarian Capital, LLC | 1,340,631 | $1.81M | 0.52% | −500,000−27.2% | Reduced |
| Vanguard Group Inc | 964,818 | $1.30M | 0.00% | +2,619+0.3% | Added |
| Samsara BioCapital, LLC | 700,421 | $946.0K | 0.19% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 416,739 | $561.0K | 0.00% | +51,186+14.0% | Added |
| BlackRock Inc. | 400,914 | $541.0K | 0.00% | −330,583−45.2% | Reduced |
| D. E. Shaw & Co., Inc. | 374,195 | $505.0K | 0.00% | +140,855+60.4% | Added |
| Geode Capital Management, LLC | 352,814 | $476.0K | 0.00% | +4,381+1.3% | Added |
| MYDA Advisors LLC | 350,065 | $473.0K | 0.15% | +260,091+289.1% | Added |